{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:16:29Z","timestamp":1773839789122,"version":"3.50.1"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:title>Lay Summary<\/jats:title>\n               <jats:p>This article describes the prevalence of inflammatory bowel disease in patients with gastritis, duodenitis, and peptic ulcer disease, stratified by Helicobacter pylori infection. Inflammatory boweld is less prevalent in patients with H. pylori, and no increased risk of IBD is seen after H. pylori eradication therapy.<\/jats:p>","DOI":"10.1093\/ibd\/izac202","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T13:49:24Z","timestamp":1664372964000},"page":"1005-1007","source":"Crossref","is-referenced-by-count":12,"title":["Inflammatory Bowel Disease and <i>Helicobacter pylori<\/i>: Protective or Present?"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1204-1550","authenticated-orcid":false,"given":"Samuel","family":"Tanner","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University Hospitals Cleveland Medical Center , Cleveland, Ohio , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffry","family":"Katz","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center , Cleveland, Ohio , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1571-1548","authenticated-orcid":false,"given":"Fabio","family":"Cominelli","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center , Cleveland, Ohio , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7681-8111","authenticated-orcid":false,"given":"Miguel","family":"Regueiro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic Foundation , Cleveland, Ohio , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Cooper","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center , Cleveland, Ohio , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Mansoor","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center , Cleveland, Ohio , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"issue":"2","key":"2023060108034051700_CIT0001","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology."},{"issue":"1","key":"2023060108034051700_CIT0002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Alatab","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"2","key":"2023060108034051700_CIT0003","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/gutjnl-2015-310545","article-title":"Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis","volume":"66","author":"Castan\u00f5-Rodr\u00edguez","year":"2017","journal-title":"Gut."},{"issue":"10","key":"2023060108034051700_CIT0004","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1136\/gut.35.10.1385","article-title":"Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine","volume":"35","author":"El-Omar","year":"1994","journal-title":"Gut."},{"issue":"10","key":"2023060108034051700_CIT0005","doi-asserted-by":"crossref","first-page":"1234567890","DOI":"10.1038\/s41419-018-0982-2","article-title":"Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract","volume":"9","author":"Yu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"10","key":"2023060108034051700_CIT0006","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.cgh.2019.02.013","article-title":"Does eradication of helicobacter pylori cause inflammatory bowel disease?","volume":"17","author":"Burisch","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"2023060108034051700_CIT0007","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","article-title":"Environmental triggers in IBD: a review of progress and evidence","volume":"15","author":"Ananthakrishnan","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"4","key":"2023060108034051700_CIT0008","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2036.2011.04969.x","article-title":"Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease","volume":"35","author":"Sonnenberg","year":"2012","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"2023060108034051700_CIT0009","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.cgh.2018.12.014","article-title":"Effects of anti-helicobacter pylori therapy on incidence of autoimmune diseases, including inflammatory bowel diseases","volume":"17","author":"Lin","year":"2019","journal-title":"Clin Gastroenterol Hepatol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izac202\/46127159\/izac202.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/29\/6\/1005\/50463349\/izac202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/29\/6\/1005\/50463349\/izac202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T08:04:43Z","timestamp":1685606683000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/29\/6\/1005\/6726164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":9,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,9,28]]},"published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izac202","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,1]]},"published":{"date-parts":[[2022,9,28]]}}}